About this episode

Chadi Nabhan interviews Dr. Daniel Olson about TIL therapy in melanoma and its clinical implications.

Chadi sits down with Dr. Daniel Olson to discuss the growing excitement surrounding tumor-infiltrating lymphocyte (TIL) therapy in melanoma, including how these personalized cellular therapies are created (and sometimes engineered in the lab), the logistical challenges of collection and reinfusion, and the clinical data that led to FDA approval based on a single-arm study. Dr. Olson also explores treatment sequencing with immunotherapy and targeted therapy, the severity and duration of associ...

Explore listener stats, chart rankings, contacts and more on the Healthcare Unfiltered podcast page.